Laura G. Eichorn - Aug 16, 2022 Form 4 Insider Report for Imago BioSciences, Inc. (IMGO)

Signature
/s/ Hugh Rienhoff, as Attorney-in-fact for Laura Eichorn
Stock symbol
IMGO
Transactions as of
Aug 16, 2022
Transactions value $
-$15,384
Form type
4
Date filed
8/18/2022, 05:50 PM
Previous filing
Jul 21, 2022
Next filing
Aug 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGO Common Stock Options Exercise $1.34K +533 +0.26% $2.52* 208K Aug 16, 2022 Direct F1
transaction IMGO Common Stock Sale -$10.4K -533 -0.26% $19.50 208K Aug 16, 2022 Direct F1
transaction IMGO Common Stock Options Exercise $940 +373 +0.18% $2.52* 208K Aug 17, 2022 Direct F1
transaction IMGO Common Stock Sale -$7.27K -373 -0.18% $19.50 208K Aug 17, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGO Stock Option (Right to Buy) Options Exercise $0 -533 -0.53% $0.00 100K Aug 16, 2022 Common Stock 533 $2.52 Direct F1
transaction IMGO Stock Option (Right to Buy) Options Exercise $0 -373 -0.37% $0.00 100K Aug 17, 2022 Common Stock 373 $2.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The transaction was executed in multiple trades in prices ranging from $19.50 to $19.51, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Remarks:

Chief Financial Officer